deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT00544700

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Bevacizumab Maintenance Versus no Maintenance After Stop of First-line Chemotherapy in Patients With Metastatic Colorectal Cancer. A Randomized Multicenter Phase III Non-inferiority Trial

Sponsor: Swiss Cancer Institute

Updated 13 times since 2017 Last updated: Feb 18, 2020 Started: Nov 26, 2007 Primary completion: Jan 21, 2013 Completion: Dec 12, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Data collection is completed. As no changes in the endpoints were expected in the future, no further data is needed.

Listed as NCT00544700, this PHASE3 trial focuses on Colorectal Cancer and remains terminated or withdrawn. Sponsored by Swiss Cancer Institute, it has been updated 13 times since 2007, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshot~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Apr 2019 · 5 months · monthly snapshot~Apr 2019 – ~Mar 2020 · 11 months · monthly snapshot~Mar 2020 – ~Nov 2020 · 8 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

13 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Aug 2025 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Sep 2024 — Aug 2025 [monthly]

    Terminated PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  5. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE3

Show 8 earlier versions
  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE3

  2. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE3

  3. Mar 2020 — Nov 2020 [monthly]

    Terminated PHASE3

    Status: Active Not RecruitingTerminated

  4. Apr 2019 — Mar 2020 [monthly]

    Active Not Recruiting PHASE3

  5. Nov 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE3

  6. Jun 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE3

  7. Jun 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  8. Jan 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Swiss Cancer Institute
Data source: Swiss Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .